Scholarlink

Background <p>The GENDER-Q is a patient-reported outcome measure (PROM) designed to assess outcomes and experiences of gender-affirming care from the patient’s perspective. The aim of this study was to translate the GENDER-Q into a linguistically validated Canadian French version.</p> Methodology <p>We followed methods according to the Professional Society for Health Economics and Outcomes Research guidelines (formerly ISPOR) for PROM translation and cultural adaptation. This involved two forward translations, reconciliation, one back translation, review of the back translation, and cognitive debriefing interviews with individuals who identify as transgender and gender diverse (TGD).</p> Results <p>The field test version of the GENDER-Q consisted of 55 scales with 959 items. This version was translated into Canadian French by two independent translators. The scales were back translated from Canadian French to English, then compared to the original English version to identify conceptual discrepancies. Based on the back translation, instructions for 13 scales, response options for 10 scales and 96 items required discussion and re-translation. Ten individuals who identified as TGD and were fluent in Canadian French reviewed the translated GENDER-Q via an online survey and subsequently participated in a cognitive debriefing interview to discuss scale components that, based on survey responses, were identified as difficult to understand. Participant feedback led to further re-wording of instructions, response options and items. The translation was reviewed to ensure consistency in the wording of recurring terms across the different scales.</p> Conclusions <p>The GENDER-Q was translated and linguistically validated in Canadian French and can be used to inform gender-affirming care, clinical research, and quality improvement efforts.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Canadian French translation and linguistic validation of a new patient-reported outcome measure for gender-affirming care: the GENDER-Q

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月5日

查看全文
  • Sylvie D. Cornacchi,
  • Ines Ndzana Siani,
  • Julia Sapin-Leduc,
  • Flavie Guibert-Piché,
  • Trisia Breitkopf,
  • Charlene Rae,
  • Hanya Obsieh,
  • Manraj N. Kaur,
  • Yi Wang,
  • Alexis Laungani,
  • Andrea L. Pusic,
  • Anne F. Klassen

摘要

Background

The GENDER-Q is a patient-reported outcome measure (PROM) designed to assess outcomes and experiences of gender-affirming care from the patient’s perspective. The aim of this study was to translate the GENDER-Q into a linguistically validated Canadian French version.

Methodology

We followed methods according to the Professional Society for Health Economics and Outcomes Research guidelines (formerly ISPOR) for PROM translation and cultural adaptation. This involved two forward translations, reconciliation, one back translation, review of the back translation, and cognitive debriefing interviews with individuals who identify as transgender and gender diverse (TGD).

Results

The field test version of the GENDER-Q consisted of 55 scales with 959 items. This version was translated into Canadian French by two independent translators. The scales were back translated from Canadian French to English, then compared to the original English version to identify conceptual discrepancies. Based on the back translation, instructions for 13 scales, response options for 10 scales and 96 items required discussion and re-translation. Ten individuals who identified as TGD and were fluent in Canadian French reviewed the translated GENDER-Q via an online survey and subsequently participated in a cognitive debriefing interview to discuss scale components that, based on survey responses, were identified as difficult to understand. Participant feedback led to further re-wording of instructions, response options and items. The translation was reviewed to ensure consistency in the wording of recurring terms across the different scales.

Conclusions

The GENDER-Q was translated and linguistically validated in Canadian French and can be used to inform gender-affirming care, clinical research, and quality improvement efforts.